home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Trial Master File for Research Sites: Can You Pass FDA Inspection?

 
  June 27, 2012  
     
 
ComplianceOnline, Online Event
2012-07-27


Why Should You Attend:

Your clinical trial has zero chance of passing an FDA inspection or QA audit if your Trial Master File (TMF) is not in order.

The FDA frequently states that if compliance isn't documented, it didn't happen. Your TMF serves as living proof that you are adhering to GCP, and that your quality system is in a state of control. Beyond simply being a get out of jail free card, a well-maintained TMF can make trial management easier; with a typical TMF containing thousands of pages of documentation, you could easily save, or lose, hundreds of hours over the life of a trial searching for individual pieces of knowledge.

Areas Covered in the Seminar:

  • Documents that should, and should not, make up a Trial Master File.
  • Maintenance and quality control of the TMF.
  • Start smart—the steps to take from Day One to create a compliant and useful TMF.
  • Red flags that scream "noncompliance".
  • Common pain points that you can expect to encounter, and how to keep them from driving your TMF into noncompliance.
  • Note to File (NTF).
  • CRA contributions to and adequate monitoring of the investigator TMF.

 

 
 
Organized by: Complianceonline
Invited Speakers:

Madhavi Diwanji, MBA, CCRC is the President of MD Clinical Monitor. She has tremendous experience in the healthcare industry in various roles for the past 20 years. She is well rounded in all aspects of clinical trial as she has been instrumental in healthcare research with a primary focus on cardiology and oncology. She has experience with monitoring clinical trials, conducting clinical trials, investigator initiated trials, maintaining multiple Trial Master Files, starting a research program in a hospital, health services research, regulatory /compliance submission and management, grant submission, business development and fundraising. She has successfully worked with different IRBs, CROs and sponsors. She has served on a study coordinator advisory committee of a global Congestive Heart failure clinical trial. She currently consults with helping clinical research departments in need services like starting up, regulatory, closing down and increasing productivity.

 
Deadline for Abstracts: 2012-07-26
 
Registration:

For Registration:

http://www.complianceonline.com/ecommerce/control/trainingFocus/~product_id=701864?channel=hummolgen

E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.